SteadyMed and Cardiome Enter into a License Agreement for the Commercialization Rights to Trevyent Outside the U.S.

SteadyMed Ltd. (Nasdaq: STDY), a specialty pharmaceutical company focused on the development of drug products to treat orphan and high ...